Viewing Study NCT00526669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-02-27 @ 5:38 PM
Study NCT ID: NCT00526669
Status: COMPLETED
Last Update Posted: 2016-01-29
First Post: 2007-09-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms, Gastrointestinal Tract View
Keywords:

Keywords

Keyword Brief Keyword Text View
None tumor biopsy View
None capecitabine View
None first line View
None Gastro Esophageal (GE) Junction Cancer View
None Gastric cancer View
None newly diagnosed View
None GE junction View
None lapatinib View
None metastatic or unresectable View